Differentially expressed proteins in nitric oxide-stimulated NIH/3T3 fibroblasts: implications for inhibiting cancer

Dong Hwi Shim1, Joo Weon Lim2, Hyeyoung Kim3

  • 1Department of Pharmacology, College of Medicine, Yonsei University, Seoul, Korea.

Yonsei Medical Journal
|February 17, 2015
PubMed
Abstract

Insights

Nitric oxide (NO) treatment of NIH/3T3 fibroblasts altered protein expression. Most identified proteins were associated with inhibiting cancer development, suggesting a potential anti-cancer role for NO.

Area of Science:

  • Proteomics
  • Cell Biology
  • Cancer Research

Background:

  • Nitric oxide (NO) has demonstrated dual roles in cancer, exhibiting both pro-cancer and anti-cancer activities.
  • Understanding the specific protein expression changes induced by NO is crucial for elucidating its complex effects on cancer.

Purpose of the Study:

  • To identify differentially expressed proteins in NIH/3T3 fibroblasts following treatment with a nitric oxide donor.
  • To investigate whether NO induces proteins with pro-cancer or anti-cancer effects.

Main Methods:

  • NIH/3T3 fibroblasts were treated with 300 μM of the NO donor NOC-18 for 12 hours.
  • Differential protein expression was analyzed using two-dimensional electrophoresis (pH 4-7).
  • Identified proteins were confirmed via MALDI-TOF MS analysis of peptide digests.

Main Results:

  • Seventeen differentially expressed proteins were identified.
  • Nine proteins, including vinculin and heat shock protein 90, were upregulated.
  • Eight proteins, such as heat shock protein 70 and calreticulin, were downregulated.
  • Thirteen proteins are linked to the suppression of cancer cell proliferation, invasion, and metastasis.
  • Two proteins, heat shock protein 90 and N(G)-dimethylarginine dimethylaminohydrolase, are associated with carcinogenesis.

Conclusions:

  • The majority of proteins differentially expressed by NOC-18 treatment are involved in inhibiting cancer development.
  • This suggests a predominantly anti-cancer effect mediated by NO through specific protein modulation.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.9K